EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Costas Schulze
Stephen M. Wildhirt
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egi, K.
Right arrow Articles by Wildhirt, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egi, K.
Right arrow Articles by Wildhirt, S. M.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Myocardial protection
Right arrow Transplantation - heart

Eur J Cardiothorac Surg 2004;26:262-269
© 2004 Elsevier Science NL


Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts

Koso Egia, Nicole E. Conrada, Jennifer Kwanb, Costas Schulzea, Richard Schulzb, Stephen M. Wildhirta*

a Department of Cardiac Surgery, Ludwig-Maximilians-University, Munich, Germany
b Department of Pediatrics and Pharmacology, University of Alberta, Edmonton, Canada

Received 24 September 2003; received in revised form 1 March 2004; accepted 6 April 2004.

* Corresponding author. Address: Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Lazorett Str. 36, 80636 Munich, Germany. Tel.: +49-89-1218-4063; fax: +49-89-1218-4123
e-mail: wildhirt{at}gmx.net

Objective: Oxidants such as nitric oxide (NO) and superoxide are involved in coronary endothelial dysfunction, an early event in the process of allograft coronary atherogenesis, possibly by activation of matrix metalloproteinases (MMPs) and extracellular matrix proteins. We investigated the contribution of inducible nitric oxide synthase (iNOS) derived NO and superoxide on (MMP)-9 activity and to changes in coronary vasomotor function in rat cardiac allografts. Methods and Results: An allogenic (Brown Norway to Lewis rats) heterotopic cardiac transplantation model was used to study the effect of continuous treatment with a selective iNOS inhibitor; N-(3-(aminomethyl) benzyl) acetamidine (1400W), and polyethylene glycol conjugated superoxide dismutase (SOD) either alone or in combination on coronary vasomotor dysfunction. 1400W or SOD 24 h alone or their combination improved endothelium-dependent (bradykinin) and -independent (sodium nitroprusside) coronary flow reserve and inhibited enhanced MMP-9 protein and activity. In addition, histopathological study revealed that either 1400W or SOD or their combination reduced superoxide production and nitrotyrosine protein. Conclusion: The present study demonstrates for the first time that selective iNOS inhibition or SOD treatment reduces enhanced MMP-9 protein and activity associated with improvement of both, endothelium-dependent and -independent coronary vasomotor function in rat cardiac allografts. This is accompanied by reduction of nitrotyrosine and superoxide production. This suggests that the proteolytic enzyme MMP-9 is an effector molecule of oxidant-mediated coronary vasomotor dysfunction.

Key Words: Nitric oxide synthase • Superoxide • Matrix metalloproteinases • Transplantation • Endothelium




This article has been cited by other articles:


Home page
CirculationHome page
I. Ikonomidis, J. P. Lekakis, M. Nikolaou, I. Paraskevaidis, I. Andreadou, T. Kaplanoglou, P. Katsimbri, G. Skarantavos, P. N. Soucacos, and D. T. Kremastinos
Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
Circulation, May 20, 2008; 117(20): 2662 - 2669.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Marcet-Palacios, M. Ulanova, F. Duta, L. Puttagunta, S. Munoz, D. Gibbings, M. Radomski, L. Cameron, I. Mayers, and A. D. Befus
The Transcription Factor Wilms Tumor 1 Regulates Matrix Metalloproteinase-9 through a Nitric Oxide-Mediated Pathway
J. Immunol., July 1, 2007; 179(1): 256 - 265.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Cuenca, P. Martin-Sanz, A. M. Alvarez-Barrientos, L. Bosca, and N. Goren
Infiltration of Inflammatory Cells Plays an Important Role in Matrix Metalloproteinase Expression and Activation in the Heart during Sepsis
Am. J. Pathol., November 1, 2006; 169(5): 1567 - 1576.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. Mehra, P. A. Uber, D. Walther, M. Vesely, J. G. Wohlgemuth, J. Prentice, D. Tayama, and M. Billingham
Gene Expression Profiles and B-Type Natriuretic Peptide Elevation in Heart Transplantation: More Than a Hemodynamic Marker
Circulation, July 4, 2006; 114(1_suppl): I-21 - I-26.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.